Oberon Pharmaceuticals Private Limited, a active private limited company, was established on 27 April 2010 in Thrissur, Kerala, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24233KL2010PTC025908. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹4.48 M.
It upholds a compliant status. Its leadership includes Visembharan Koovel Jithin (Managing Director), Alby Joseph (Director). Past directors included Jose Rapheal, Jijo Jose Tharakan, Vimal Vincent. It holds ₹4.00 M open charges and ₹3.00 M settled loans. Its latest AGM occurred on 30 November 2024, with the balance sheet filed on 31 March 2024. It is based at Xxvi/1281, 1St Floor Chettupuzha Building, Palakkal Angadi, Thrissur, Kerala, 680001.
U24233KL2010PTC025908
025908
27 April 2010
₹5.00 M
₹4.48 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Oberon Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Visembharan Koovel Jithin | Managing Director | 03 Jul 2023 | Current |
| Alby Joseph | Director | 03 Jul 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Sep 2021 | Past |
| Pramod Abcsdd | Director | 18 Aug 2011 | Past |
| Pramod Abcsdd | Director | 18 Aug 2011 | Past |
| Pramod Abcsdd | Director | 17 Jul 2023 | Past |
| Pramod Abcsdd | Director | 17 Jul 2023 | Past |
| Pramod Abcsdd | Director | 07 Aug 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Oberon Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 26.37% decrease. The company also saw a substantial fall in profitability, with a 5630.92% decrease in profit. The company's net worth observed a substantial decline by a decrease of 59.57%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Oberon Pharmaceuticals had a promoter holding of 7.04% and a public holding of 92.96%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹4,000,000.00
₹3,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Oct 2016 | Others | ₹4.00 M | Open |
| 08 Dec 2011 | The Catholic Syrian Bank Limited | ₹3.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Oberon Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Oberon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oberon Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Oberon Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Nov 2024 as per latest MCA records. was recorded as a recent event.
Oberon Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was recorded as a recent event.
The activity Visembharan Koovel Jithin was appointed as a Managing Director was appointed as a Managing Director on 03 Jul 2023 & has been associated with this company since 2 years 5 months . was completed.
Progress on Alby Joseph was appointed as a Director was appointed as a Director on 03 Jul 2023 & has been associated with this company since 2 years 5 months . was documented.
A charge registered on 08 Dec 2011 via Charge ID 10325926 with The Catholic Syrian Bank Limited was fully satisfied on 20 Jan 2021. was recorded as a recent event.
A charge with Others amounted to Rs. 4.00 M with Charge ID 100063779 was registered on 25 Oct 2016. was recorded as a recent event.
The CIN of Oberon Pharmaceuticals Private Limited is U24233KL2010PTC025908.
Oberon Pharmaceuticals Private Limited is headquartered at Xxvi/1281, 1St Floor Chettupuzha Building, Palakkal Angadi, Thrissur, Kerala, 680001.
Oberon Pharmaceuticals Private Limited was incorporated on 27 April 2010.
The current directors of Oberon Pharmaceuticals Private Limited are
The primary industry of Oberon Pharmaceuticals Private Limited is Trade.
Oberon Pharmaceuticals Private Limited is unlisted.
The authorized capital of Oberon Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹4.48 M.
The compliance status of Oberon Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX